Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartphone rehab: a new way to heal hearts and lungs from home

NCT ID NCT02791685

Disease control Sponsor: Emory University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a smartphone app and regular phone calls could help people with heart or lung disease complete rehabilitation at home instead of going to a clinic. The program included exercise tracking, education, and counseling over 12 weeks. Researchers wanted to see if this approach improved patients' fitness, symptom monitoring, and reduced hospital stays compared to standard care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MULTIFIT Cardiac Rehabilitation and Movn Pulmonary Rehabilitation (behavioral programs delivered via smartphone app)
What this could lead to
If successful, this could make cardiac and pulmonary rehab more accessible and convenient for patients, potentially improving recovery and reducing hospital readmissions.
What could go wrong
This is a completed study, but results may not apply to all patients or settings. The app-based approach relies on patient engagement and technology access, which may limit its effectiveness for some.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

258 people

The number who actually took part.

Start date

May 2016

Finished

Mar 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Meet eligibility for cardiac rehabilitation program as defined by Centers for Medicare \& Medicaid Services (CMS); they may also have stable CAD and be referred for cardiac rehab by their provider. 1. Following acute myocardial infarction (within the preceding 12 months) 2. Coronary artery bypass grafting (CABG) 3. Current stable angina pectoris 4. Heart valve repair or replacement 5. Percutaneous transluminal coronary angioplasty (PTCA) or coronary stenting 6. Heart or heart-lung transplant 7. Other diagnosis by specific physician referral Exclusion Criteria: * Unstable angina * Resting systolic blood pressure \>200 mm Hg or resting diastolic blood pressure \>110 mm Hg * Significant drop (\>=20 mm Hg) in resting systolic blood pressure from the patient's average level that cannot be explained by medications * Moderate to severe aortic stenosis * Acute systemic illness or fever * Uncontrolled atrial or ventricular arrhythmias * Symptomatic congestive heart failure (stage C) * Third-degree heart block without pacemaker * Active pericarditis or myocarditis * Recent venous thromboembolism (VTE, as determined by physician) * Current Thrombophlebitis * Uncontrolled diabetes (A1c \> 7.0 or as determined by physician) * Orthopedic problems that would prohibit exercise * Other by specific physician instruction * Peripheral vascular disease (PVD; symptomatic or that would prohibit exercise)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute myocardial infarction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute myocardial infarction cardiovascular disorder coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiovascular disease Coronary artery disease

Contacts and locations

Locations

  • Atlanta VA Medical Center

    Atlanta, Georgia, 30033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.